Evaluation on the compliance with secondary prevention and influence factors of ischemic stroke in Hainan province,China

Abstract

Survivors of ischemic stroke are still at a significant risk for recurrence. Numerous effective strategies for the secondary prevention of ischemic stroke have now been established; however, these guidelines are not widely known. In this retrospective, a multicenter study was conducted from January 2011 to February 2012 in 10 general hospitals, which included 1300 elderly patients who had previously been diagnosed with ischemic stroke and re-admitted to hospitals. Logistic regression models were fitted to determine the relationship between compliance with secondary prevention therapy and each variable of interest. The treatment rates of antihypertensive, antiplatelet and lipid-lowering therapy were only 56.3%, 48.9% and 19.6%, respectively. Multivariate analysis presented that cardiovascular risk factors would motivate patients with hypertension and hyperlipidemia to receive corresponding treatments. However, it is worth noting that they did not influence the use of antiplatelet therapy. In addition, high education, health education and insurance promote the use of secondary prevention in patients. In conclusion, the importance of antiplatelet therapy should not be ignored any more. Besides, health education will raise patients’ attention to ischemic stroke.

Keywords

Ischemic stroke Hainan province China secondary prevention compliance

Get full access to this article

View all access options for this article.

References

Chen

Bona

. Association between plasma homocysteine levels and obstructive sleep apnoea in patients with ischemic stroke. J Clin Neurosci 2011; 18(11): 1454–1457.

Demaerschalk

Hwang

Leung

. US cost burden of ischemic stroke: a systematic literature review. Am J Manag Care 2010; 16(7): 525–533.

Wang

Zhang

. Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack 2010. CNS Neurosci Ther 2012; 18(2): 93–101.

Wei

Wang

Huang

. Secondary prevention of ischemic stroke in urban China. Stroke 2010; 41(5): 967–974.

D'Agostino

Wolf

Belanger

. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 1994; 25(1): 40–43.

Wang

Massaro

Levy

. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 2003; 290(8): 1049–1056.

Asberg

Henriksson

Farahmand

. Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register. Stroke 2010; 41(7): 1338–1342.

Donnan

Fisher

Macleod

. Stroke. Lancet 2008; 371(9624): 1612–1623.

Kammersgaard

Olsen

. Cardiovascular risk factors and 5-year mortality in the Copenhagen Stroke Study. Cerebrovasc Dis 2006; 21(3): 187–193.

10.

Chinese Medical Association. Chinese secondary prevention guidelines for ischemic stroke and transient ischemic attack (2010). Chin J Neurol 2010; 43(2): 154–160.

11.

National Board of Health and Welfare. National Guidelines on Stroke Care, http://www.socialstyrelsen.se/nationellariktlinjer (2007, accessed 4 June 2013).

12.

Gotto

AMJ

. Stain therapy and reduced incidence of stroke. Implications of cholesterol-lowering therapy for cerebrovascular disease. Arch Intern Med 1997; 157(12): 1283–1284.

13.

Lutsep

. Recent clinical trials of antiplatelet therapy in secondary stroke prevention: expectations and results for application in primary care settings. Am J Med 2009; 122(4 Suppl. 2): S21–S31.

14.

Zhou

. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 2002; 15(1): 83–96.

15.

Paciaroni

Bogousslavsky

. Primary and secondary prevention of ischemic stroke. Eur Neurol 2010; 63(5): 267–278.

16.

Hackam

Spence

. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke 2007; 38(6): 1881–1885.

17.

Holloway

Benesch

Rush

. Stroke prevention: narrowing the evidence-practice gap. Neurology 2000; 54(10): 1899–1906.

18.

WANG

Zhang

. Status of secondary prevention of 541 recurrent ischemic stroke or TIA patients. Chin J Nervous Mental Dis 2010; 10: 594–597. in Chinese.

19.

Abbott

. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009; 40(10): e573–e583.

20.

Naylor

Mehta

Rothwell

. A systematic review and meta-analysis of 30-day outcomes following staged carotid artery stenting and coronary bypass. Eur J Vasc Endovasc Surg 2009; 37(4): 379–387.

21.

Spence

. Asymptomatic carotid stenosis: mainly a medical condition. Vascular 2010; 18(3): 123–126.

22.

Adams

Albers

Alberts

. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2008; 39(5): 1647–1652.

23.

Sacco

Adams

Albers

. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 2006; 113(10): 409–449.